$RGBP
Regen BioPharma Inc Stock $rgbp

$rgbp Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000160706222000477 Filed on July 22, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$59.37K	$31.29K	$58.37K
YoY Change	-0.57%	7.14%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$92.88K	$86.57K	$70.50K
YoY Change	-43.96%	2.0%	-16.73%
% of Gross Profit
Research & Development	$64.27K	$31.06K	$64.37K
YoY Change	208.84%	117.91%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$157.1K	$31.06K	$134.9K
YoY Change	-15.76%	117.91%	56.27%
Operating Profit		-$58.91K	-$76.49K
YoY Change		38.64%
Interest Expense	$65.25K	$30.40K	-$66.71M
YoY Change	-113.53%	-48.97%	-3217.06%
% of Operating Profit
Other Income/Expense, Net	-$45.50K	$0.00	-$300.0K
YoY Change
Pretax Income	-$78.03K	$66.96M	-$67.08M
YoY Change	-94.36%	-994.07%	-3281.41%
Income Tax
% Of Pretax Income
Net Earnings	-$78.03K	$66.96M	-$67.08M
YoY Change	-94.36%	-994.07%	-15270.55%
Net Earnings / Revenue	-131.42%	213978.54%	-114924.77%
Basic Earnings Per Share
Diluted Earnings Per Share	-$17.60	$14.00K	-$14.70K
COMMON SHARES
Basic Shares Outstanding	4.970B shares	3.189M shares	3.043M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$51.20K	$111.0K	$234.7K
YoY Change	-92.96%	-41.02%
Cash & Equivalents	$51.20K	$111.0K	$234.7K
Short-Term Investments
Other Short-Term Assets	$30.95K	$27.80K	$34.58K
YoY Change	-35.71%
Inventory
Prepaid Expenses	$20.95K	$27.80K
Receivables	$254.3K	$295.5K	$268.0K
Other Receivables	$0.00	$6.020K	$5.890K
Total Short-Term Assets	$336.4K	$440.3K	$543.2K
YoY Change	-66.16%	16.13%	243.68%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$222.6K	$249.4K	$87.68K
YoY Change	2.11%	-76.35%	339.06%
Other Assets		$0.00
YoY Change
Total Long-Term Assets	$222.6K	$249.4K	$87.68K
YoY Change	2.11%	-76.35%	339.06%
TOTAL ASSETS
Total Short-Term Assets	$336.4K	$440.3K	$543.2K
Total Long-Term Assets	$222.6K	$249.4K	$87.68K
Total Assets	$559.0K	$689.7K	$630.9K
YoY Change	-53.88%	-51.89%	254.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$28.80K	$28.80K	$41.63K
YoY Change	-68.52%	-71.26%	-64.46%
Accrued Expenses	$2.002M	$2.004M	$1.977M
YoY Change	-11.69%	-12.72%	-12.62%
Deferred Revenue
YoY Change
Short-Term Debt	$1.710K	$1.230K	$1.230K
YoY Change	-99.88%	-91.92%	-98.05%
Long-Term Debt Due	$1.272M	$1.581M	$2.997M
YoY Change	-40.9%	-33.12%	20.69%
Total Short-Term Liabilities	$8.595M	$9.039M	$77.38M
YoY Change	-41.52%	-34.71%	1374.27%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.595M	$9.039M	$77.38M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$8.595M	$9.039M	$77.38M
YoY Change	-41.52%	-34.71%	1374.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$20.91M	-$20.83M
YoY Change	-10.47%
Common Stock	$503.2K	$492.0K
YoY Change	15.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$8.036M	-$8.350M	-$76.75M
YoY Change
Total Liabilities & Shareholders Equity	$559.0K	$689.7K	$630.9K
YoY Change	-53.88%	-51.89%	254.38%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$78.03K	$66.96M	-$67.08M
YoY Change	-94.36%	-994.07%	-15270.55%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$85.29K	-$123.7K	-$118.8K
YoY Change	-92.01%	93.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$25.00K		$0.00
YoY Change	-87.18%
Cash From Investing Activities	$25.00K		$0.00
YoY Change	-87.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	500.0	0.000	0.000
YoY Change	-99.96%	-100.0%
NET CHANGE
Cash From Operating Activities	-85.29K	-123.7K	-118.8K
Cash From Investing Activities	25.00K		0.000
Cash From Financing Activities	500.0	0.000	0.000
Net Change In Cash	-59.79K	-123.7K	-118.8K
YoY Change	-111.09%	-165.72%
FREE CASH FLOW
Cash From Operating Activities	-$85.29K	-$123.7K	-$118.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001589150
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-191725
	dei	Entity Registrant Name EntityRegistrantName	REGEN BIOPHARMA, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-5192997
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4700 Spring Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	St 304
	dei	Entity Address City Or Town EntityAddressCityOrTown	La Mesa
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91942
	dei	City Area Code CityAreaCode	619
	dei	Local Phone Number LocalPhoneNumber	722-5505
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4970002832	shares
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	us-gaap	Cash Cash	110993	usd
CY2021Q3	us-gaap	Cash Cash	727162	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	295466	usd
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	213192	usd
CY2022Q2	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	5396	usd
CY2021Q3	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	5396	usd
CY2022Q2	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	629	usd
CY2021Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	230	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	27801	usd
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	48144	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	440286	usd
CY2021Q3	us-gaap	Assets Current AssetsCurrent	994124	usd
CY2022Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	26828	usd
CY2021Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	198006	usd
CY2022Q2	RGBP	Investment Securities Related Party InvestmentSecuritiesRelatedParty	222580	usd
CY2021Q3	RGBP	Investment Securities Related Party InvestmentSecuritiesRelatedParty	19969	usd
CY2022Q2	us-gaap	Other Assets OtherAssets	249408	usd
CY2021Q3	us-gaap	Other Assets OtherAssets	217975	usd
CY2022Q2	us-gaap	Assets Assets	689693	usd
CY2021Q3	us-gaap	Assets Assets	1212099	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	28799	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	91498	usd
CY2022Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	227	usd
CY2021Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1429179	usd
CY2022Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	4241	usd
CY2021Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	4241	usd
CY2022Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	691985	usd
CY2021Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	954861	usd
CY2021Q3	RGBP	Accrued Rent AccruedRent	0	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1266679	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1266679	usd
CY2022Q2	RGBP	Other Accrued Expenses OtherAccruedExpenses	41423	usd
CY2021Q3	RGBP	Other Accrued Expenses OtherAccruedExpenses	41423	usd
CY2022Q2	us-gaap	Bank Overdrafts BankOverdrafts	1000	usd
CY2021Q3	us-gaap	Bank Overdrafts BankOverdrafts	1000	usd
CY2022Q2	RGBP	Due To Investor DueToInvestor	20000	usd
CY2021Q3	RGBP	Due To Investor DueToInvestor	20000	usd
CY2022Q2	RGBP	Unearned Income UnearnedIncome	1749930	usd
CY2021Q3	RGBP	Unearned Income UnearnedIncome	1843806	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	3654003	usd
CY2021Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	6892477	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1571090	usd
CY2021Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2131311	usd
CY2022Q2	RGBP	Convertible Notes Payable Related Parties Less Unamortized Discount ConvertibleNotesPayableRelatedPartiesLessUnamortizedDiscount	10000	usd
CY2021Q3	RGBP	Convertible Notes Payable Related Parties Less Unamortized Discount ConvertibleNotesPayableRelatedPartiesLessUnamortizedDiscount	21500	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9039377	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14697976	usd
CY2021Q3	RGBP	Convertible Notes Payable Related Parties Less Unamortized Discount Noncurrent ConvertibleNotesPayableRelatedPartiesLessUnamortizedDiscountNoncurrent	0	usd
CY2022Q2	us-gaap	Liabilities Liabilities	9039377	usd
CY2021Q3	us-gaap	Liabilities Liabilities	14697976	usd
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5800000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4920002832	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4800000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4350554514	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	491999	usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	435054	usd
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	800000000	shares
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11200998	usd
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8644037	usd
CY2022Q2	us-gaap	Other Additional Capital OtherAdditionalCapital	736326	usd
CY2021Q3	us-gaap	Other Additional Capital OtherAdditionalCapital	736326	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20827342	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23348900	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8349684	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13485877	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	689693	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1212099	usd
CY2022Q2	us-gaap	Revenues Revenues	31292	usd
CY2021Q2	us-gaap	Revenues Revenues	29206	usd
	us-gaap	Revenues Revenues	93877	usd
	us-gaap	Revenues Revenues	29206	usd
CY2022Q2	RGBP	Revenues Related Party RevenuesRelatedParty	27425	usd
CY2021Q2	RGBP	Revenues Related Party RevenuesRelatedParty	27425	usd
	RGBP	Revenues Related Party RevenuesRelatedParty	82274	usd
	RGBP	Revenues Related Party RevenuesRelatedParty	82274	usd
CY2022Q2	RGBP	Total Revenues TotalRevenues	58717	usd
CY2021Q2	RGBP	Total Revenues TotalRevenues	56631	usd
	RGBP	Total Revenues TotalRevenues	176151	usd
	RGBP	Total Revenues TotalRevenues	111480	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31061	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14254	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	93869	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15893	usd
CY2022Q2	RGBP	Research And Development Related Party ResearchAndDevelopmentRelatedParty	0	usd
CY2021Q2	RGBP	Research And Development Related Party ResearchAndDevelopmentRelatedParty	0	usd
	RGBP	Research And Development Related Party ResearchAndDevelopmentRelatedParty	117250	usd
	RGBP	Research And Development Related Party ResearchAndDevelopmentRelatedParty	0	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6866	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24157	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18879	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	108821	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	64700	usd
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	50711	usd
	us-gaap	Professional Fees ProfessionalFees	152979	usd
	us-gaap	Professional Fees ProfessionalFees	50711	usd
CY2022Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	15000	usd
CY2021Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10000	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	35000	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	117627	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	99122	usd
	us-gaap	Costs And Expenses CostsAndExpenses	417977	usd
	us-gaap	Costs And Expenses CostsAndExpenses	185425	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-58910	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-42491	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-241827	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-73945	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	133	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	96	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	399	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	96	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	30399	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	59569	usd
	us-gaap	Interest Expense InterestExpense	107970	usd
	us-gaap	Interest Expense InterestExpense	198029	usd
CY2022Q2	RGBP	Interest Expense Attributable To Amortization Of Discount InterestExpenseAttributableToAmortizationOfDiscount	-22203	usd
CY2021Q2	RGBP	Interest Expense Attributable To Amortization Of Discount InterestExpenseAttributableToAmortizationOfDiscount	-414	usd
	RGBP	Interest Expense Attributable To Amortization Of Discount InterestExpenseAttributableToAmortizationOfDiscount	-66631	usd
	RGBP	Interest Expense Attributable To Amortization Of Discount InterestExpenseAttributableToAmortizationOfDiscount	-47063	usd
CY2022Q2	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	-0	usd
CY2021Q2	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	-0	usd
	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	300000	usd
	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	-0	usd
CY2022Q2	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	161729	usd
CY2021Q2	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	-308550	usd
	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	31433	usd
	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	-308550	usd
CY2021Q2	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-206900	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-206900	usd
CY2022Q2	RGBP	Gain Loss On Derecognition Of Accounts Payable GainLossOnDerecognitionOfAccountsPayable	0	usd
CY2021Q2	RGBP	Gain Loss On Derecognition Of Accounts Payable GainLossOnDerecognitionOfAccountsPayable	0	usd
	RGBP	Gain Loss On Derecognition Of Accounts Payable GainLossOnDerecognitionOfAccountsPayable	62700	usd
	RGBP	Gain Loss On Derecognition Of Accounts Payable GainLossOnDerecognitionOfAccountsPayable	0	usd
CY2022Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	66907817	usd
CY2021Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-6871286	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3238473	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-4546175	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-95019	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	67017077	usd
CY2021Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-7446623	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2763384	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5306621	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	66958166	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-7489114	usd
	us-gaap	Net Income Loss NetIncomeLoss	2521557	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5380566	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	60931932	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7489115	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2294618	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5380566	usd
CY2022Q2	RGBP	Basic And Fully Diluted Earnings Loss Per Share BasicAndFullyDilutedEarningsLossPerShare	0.01274
CY2021Q2	RGBP	Basic And Fully Diluted Earnings Loss Per Share BasicAndFullyDilutedEarningsLossPerShare	-0.0021
	RGBP	Basic And Fully Diluted Earnings Loss Per Share BasicAndFullyDilutedEarningsLossPerShare	0.0005
	RGBP	Basic And Fully Diluted Earnings Loss Per Share BasicAndFullyDilutedEarningsLossPerShare	-0.002
CY2022Q2	RGBP	Weighted Average Number Of Common Shares Outstanding WeightedAverageNumberOfCommonSharesOutstanding	4783780610	shares
CY2021Q2	RGBP	Weighted Average Number Of Common Shares Outstanding WeightedAverageNumberOfCommonSharesOutstanding	3573338986	shares
	RGBP	Weighted Average Number Of Common Shares Outstanding WeightedAverageNumberOfCommonSharesOutstanding	4794127177	shares
	RGBP	Weighted Average Number Of Common Shares Outstanding WeightedAverageNumberOfCommonSharesOutstanding	2608298343	shares
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-7334998	usd
CY2020Q4	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	3752	usd
CY2020Q4	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	1452	usd
CY2020Q4	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	3900	usd
CY2020Q4	RGBP	Shares Issued For Interest Value1 SharesIssuedForInterestValue1	1555	usd
CY2020Q4	RGBP	Shares Issued For Debt2 Amount SharesIssuedForDebt2Amount	7300	usd
CY2020Q4	RGBP	Shares Issued For Interest Value2 SharesIssuedForInterestValue2	3142	usd
CY2020Q4	RGBP	Shares Issued For Debt3 Amount SharesIssuedForDebt3Amount	429	usd
CY2020Q4	RGBP	Shares Issued For Interest Value3 SharesIssuedForInterestValue3	236	usd
CY2020Q4	RGBP	Shares Issued For Fees Value SharesIssuedForFeesValue	159	usd
CY2020Q4	RGBP	Shares Issued For Debt4 Amount SharesIssuedForDebt4Amount	4030	usd
CY2020Q4	RGBP	Shares Issued For Interest Value4 SharesIssuedForInterestValue4	1700	usd
CY2020Q4	RGBP	Shares Issued For Debt5 Amount SharesIssuedForDebt5Amount	8200	usd
CY2020Q4	RGBP	Shares Issued For Interest Value5 SharesIssuedForInterestValue5	1700	usd
CY2020Q4	RGBP	Shares Issued For Debt6 Amount SharesIssuedForDebt6Amount	13000	usd
CY2020Q4	RGBP	Shares Issued For Interest Value6 SharesIssuedForInterestValue6	8046	usd
CY2020Q4	RGBP	Shares Issued For Debt7 Amount SharesIssuedForDebt7Amount	16000	usd
CY2020Q4	RGBP	Shares Issued For Interest Value7 SharesIssuedForInterestValue7	3250	usd
CY2020Q4	RGBP	Shares Issued For Debt8 Amount SharesIssuedForDebt8Amount	5330	usd
CY2020Q4	RGBP	Shares Issued For Interest Value8 SharesIssuedForInterestValue8	2329	usd
CY2020Q4	RGBP	Additions To Contributed Capital AdditionsToContributedCapital	1865	usd
CY2020Q4	us-gaap	Profit Loss ProfitLoss	1666367	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-5581256	usd
CY2021Q1	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	5154	usd
CY2021Q1	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	4400	usd
CY2021Q1	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	30000	usd
CY2021Q1	RGBP	Shares Issued For Interest Value1 SharesIssuedForInterestValue1	4758	usd
CY2021Q1	RGBP	Shares Issued For Debt2 Amount SharesIssuedForDebt2Amount	5260	usd
CY2021Q1	RGBP	Shares Issued For Interest Value2 SharesIssuedForInterestValue2	2492	usd
CY2021Q1	RGBP	Shares Issued For Debt3 Amount SharesIssuedForDebt3Amount	3357	usd
CY2021Q1	RGBP	Shares Issued For Interest Value3 SharesIssuedForInterestValue3	441	usd
CY2021Q1	RGBP	Shares Issued For Debt4 Amount SharesIssuedForDebt4Amount	1000	usd
CY2021Q1	RGBP	Shares Issued For Interest Value4 SharesIssuedForInterestValue4	5750	usd
CY2021Q1	RGBP	Shares Issued For Debt5 Amount SharesIssuedForDebt5Amount	3415	usd
CY2021Q1	RGBP	Shares Issued For Interest Value5 SharesIssuedForInterestValue5	84	usd
CY2021Q1	RGBP	Shares Issued For Debt6 Amount SharesIssuedForDebt6Amount	1925	usd
CY2021Q1	RGBP	Shares Issued For Interest Value6 SharesIssuedForInterestValue6	74	usd
CY2021Q1	RGBP	Additions To Contributed Capital AdditionsToContributedCapital	250	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	442183	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-5070713	usd
CY2021Q2	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	3111	usd
CY2021Q2	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	49	usd
CY2021Q2	RGBP	Preferred Shares Issued For Services PreferredSharesIssuedForServices	1	usd
CY2021Q2	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	19000	usd
CY2021Q2	RGBP	Shares Issued For Interest Value1 SharesIssuedForInterestValue1	4736	usd
CY2021Q2	RGBP	Shares Issued For Debt2 Amount SharesIssuedForDebt2Amount	3510	usd
CY2021Q2	RGBP	Shares Issued For Interest Value2 SharesIssuedForInterestValue2	1508	usd
CY2021Q2	RGBP	Shares Issued For Debt3 Amount SharesIssuedForDebt3Amount	6340	usd
CY2021Q2	RGBP	Shares Issued For Interest Value3 SharesIssuedForInterestValue3	3179	usd
CY2021Q2	RGBP	Shares Issued For Debt4 Amount SharesIssuedForDebt4Amount	2288	usd
CY2021Q2	RGBP	Shares Issued For Interest Value4 SharesIssuedForInterestValue4	680	usd
CY2021Q2	RGBP	Shares Issued For Debt5 Amount SharesIssuedForDebt5Amount	4238	usd
CY2021Q2	RGBP	Shares Issued For Interest Value5 SharesIssuedForInterestValue5	17	usd
CY2021Q2	RGBP	Shares Issued For Debt6 Amount SharesIssuedForDebt6Amount	47000	usd
CY2021Q2	RGBP	Shares Issued For Interest Value6 SharesIssuedForInterestValue6	8189	usd
CY2021Q2	RGBP	Shares Issued For Debt7 Amount SharesIssuedForDebt7Amount	7655	usd
CY2021Q2	RGBP	Shares Issued For Interest Value7 SharesIssuedForInterestValue7	2264	usd
CY2021Q2	RGBP	Shares Issued For Debt8 Amount SharesIssuedForDebt8Amount	22000	usd
CY2021Q2	RGBP	Shares Issued For Interest Value8 SharesIssuedForInterestValue8	3905	usd
CY2021Q2	RGBP	Shares Issued For Debt9 Amount SharesIssuedForDebt9Amount	1416	usd
CY2021Q2	RGBP	Shares Issued For Interest Value9 SharesIssuedForInterestValue9	729	usd
CY2021Q2	RGBP	Shares Issued For Debt10 Amount SharesIssuedForDebt10Amount	1187	usd
CY2021Q2	RGBP	Shares Issued For Interest Value10 SharesIssuedForInterestValue10	616	usd
CY2021Q2	RGBP	Shares Issued For Debt11 Amount SharesIssuedForDebt11Amount	2026	usd
CY2021Q2	RGBP	Contributed Capital ContributedCapital	2500	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-7489115	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-12411685	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-13485877	usd
CY2021Q4	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	100000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	26662	usd
CY2021Q4	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	100000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value1 SharesIssuedForInterestValue1	38837	usd
CY2021Q4	RGBP	Shares Issued For Debt2 Amount SharesIssuedForDebt2Amount	50000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value2 SharesIssuedForInterestValue2	19603	usd
CY2021Q4	RGBP	Shares Issued For Debt3 Amount SharesIssuedForDebt3Amount	50000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value3 SharesIssuedForInterestValue3	18575	usd
CY2021Q4	RGBP	Shares Issued For Interest Value4 SharesIssuedForInterestValue4	75000	usd
CY2021Q4	RGBP	Shares Issued For Debt4 Amount SharesIssuedForDebt4Amount	32075	usd
CY2021Q4	RGBP	Shares Issued For Interest Value5 SharesIssuedForInterestValue5	25000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value6 SharesIssuedForInterestValue6	10356	usd
CY2021Q4	RGBP	Shares Issued For Debt5 Amount SharesIssuedForDebt5Amount	25000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value7 SharesIssuedForInterestValue7	8883	usd
CY2021Q4	RGBP	Shares Issued For Debt6 Amount SharesIssuedForDebt6Amount	50000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value8 SharesIssuedForInterestValue8	23369	usd
CY2021Q4	RGBP	Shares Issued For Debt7 Amount SharesIssuedForDebt7Amount	100000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value9 SharesIssuedForInterestValue9	39808	usd
CY2021Q4	RGBP	Shares Issued For Debt8 Amount SharesIssuedForDebt8Amount	40000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value10 SharesIssuedForInterestValue10	14192	usd
CY2021Q4	RGBP	Shares Issued For Debt9 Amount SharesIssuedForDebt9Amount	50000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value11 SharesIssuedForInterestValue11	19012	usd
CY2021Q4	RGBP	Shares Issued For Debt10 Amount SharesIssuedForDebt10Amount	10964	usd
CY2021Q4	RGBP	Shares Issued For Debt11 Amount SharesIssuedForDebt11Amount	25000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value12 SharesIssuedForInterestValue12	11527	usd
CY2021Q4	RGBP	Shares Issued For Debt12 Amount SharesIssuedForDebt12Amount	60000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value13 SharesIssuedForInterestValue13	25440	usd
CY2021Q4	RGBP	Shares Issued For Debt13 Amount SharesIssuedForDebt13Amount	25000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value14 SharesIssuedForInterestValue14	10625	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	2644980	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-9755969	usd
CY2022Q1	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	48420	usd
CY2022Q1	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	39708	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-67081589	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-76749430	usd
CY2022Q2	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	218617	usd
CY2022Q2	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	1701	usd
CY2022Q2	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	550161	usd
CY2022Q2	RGBP	Shares Issued For Interest Value1 SharesIssuedForInterestValue1	1500	usd
CY2022Q2	RGBP	Shares Issued For Debt2 Amount SharesIssuedForDebt2Amount	334800	usd
CY2022Q2	RGBP	Shares Issued For Debt3 Amount SharesIssuedForDebt3Amount	334800	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	66958167	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-8349684	usd
	us-gaap	Net Income Loss NetIncomeLoss	2521557	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5380566	usd
	RGBP	Common Stock Issued For Expenses CommonStockIssuedForExpenses	-159	usd
	RGBP	Preferred Stock Issued As Compensation PreferredStockIssuedAsCompensation	-1	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	66631	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	47063	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-62705	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-10263	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	82275	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	82273	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	78996	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	275388	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-20343	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-28	usd
	RGBP	Increase Decrease In Contributed Capital IncreaseDecreaseInContributedCapital	4615	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-3238473	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	4546174	usd
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-93877	usd
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	1875794	usd
	RGBP	Increase Decrease In Penalties IncreaseDecreaseInPenalties	300000	usd
	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	5396	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	399	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	96	usd
	RGBP	Securities Accepted As Compensation SecuritiesAcceptedAsCompensation	1850000	usd
	RGBP	Increase Decrease In Loss On Sale Of Investment Securities IncreaseDecreaseInLossOnSaleOfInvestmentSecurities	-206900	usd
	RGBP	Unrealized Lossgain On Investment Securities UnrealizedLossgainOnInvestmentSecurities	31433	usd
	RGBP	Unrealized Lossgain On Investment Securities UnrealizedLossgainOnInvestmentSecurities	-308550	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-521634	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-63921	usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-300000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	300000	usd
	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	-47900	usd
	RGBP	Increase Decrease In Convertible Notes Payable IncreaseDecreaseInConvertibleNotesPayable	-94535	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-94535	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-47900	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-616169	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	188179	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	727162	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110993	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188179	usd
	RGBP	Common Shares Issued For Debt CommonSharesIssuedForDebt	2197762	usd
	RGBP	Common Shares Issued For Debt CommonSharesIssuedForDebt	218723	usd
	RGBP	Preferred Shares Issued For Debt PreferredSharesIssuedForDebt	75000	usd
	RGBP	Preferred Shares Issued For Debt PreferredSharesIssuedForDebt	13000	usd
	us-gaap	Interest Paid InterestPaid	27473	usd
	us-gaap	Interest Paid InterestPaid	0	usd
	RGBP	Common Shares Issued For Interest CommonSharesIssuedForInterest	309379	usd
	RGBP	Common Shares Issued For Interest CommonSharesIssuedForInterest	59592	usd
	RGBP	Preferred Shares Issued For Interest PreferredSharesIssuedForInterest	33994	usd
	RGBP	Preferred Shares Issued For Interest PreferredSharesIssuedForInterest	8046	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0298	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	8.5505	pure
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1	pure
	us-gaap	Advertising Expense AdvertisingExpense	0	usd
	RGBP	Net Income Loss Since Inception NetIncomeLossSinceInception	20827342	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	227	usd
	us-gaap	Other Expenses OtherExpenses	300000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5800000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4920002832	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	800000000	shares
CY2022Q2	us-gaap	Payments For Fees PaymentsForFees	1905000	usd
CY2022Q2	RGBP	License Term LicenseTerm	P15Y

Files In Submission

Name	View Source	Status
0001607062-22-000477-index-headers.html	Edgar Link	pending
0001607062-22-000477-index.html	Edgar Link	pending
0001607062-22-000477.txt	Edgar Link	pending
0001607062-22-000477-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex32_2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rgbp-20220630.xsd	Edgar Link	pending
rgbp-20220630_cal.xml	Edgar Link	unprocessable
rgbp-20220630_def.xml	Edgar Link	unprocessable
rgbp-20220630_lab.xml	Edgar Link	unprocessable
rgbp-20220630_pre.xml	Edgar Link	unprocessable
rgbp063022form10q.htm	Edgar Link	pending
rgbp063022form10q_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RGBP
Regen BioPharma Inc Stock $rgbp

2022 Q3 Form 10-Q Financial Statement

#000160706222000477 Filed on July 22, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGBP Regen BioPharma Inc Stock $rgbp

2022 Q3 Form 10-Q Financial Statement

#000160706222000477 Filed on July 22, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGBP
Regen BioPharma Inc Stock $rgbp